Dr. Teja Poosarla, MD
- Medicare services, 2024
- 399
- Medicare patients, 2024
- 203
- Part D claims, 2024
- 722
- Publications
- 7
- Clinical trials
- 5
- Practice address
- 1430 Paysphere Cir, Chicago, IL 60674
- Practice phone
- Call (847) 731-4151
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Midwestern Regional Medical Center
Chicago, Illinois
Find Dr. Poosarla's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Teja Poosarla is a medical oncologist in Chicago, Illinois
Dr. Poosarla practices at Midwestern Regional Medical Center in Chicago, Illinois.
Dr. Poosarla's NPI, 1932467792, was assigned on May 1, 2012. Dr. Poosarla graduated from University of South Alabama College of Medicine in 2012. Dr. Poosarla holds Virginia license 0101273767.
- NPI
- 1932467792NPI Registry (opens in a new tab)
- Medicare PAC ID
- 3173747920
- NPI enumeration date
- May 1, 2012
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (847) 731-4151
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
- Estimated age
- 40
- Medical school graduation
- 2012
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Teja Poosarla practices at Midwestern Regional Medical Center in Chicago, Illinois
Dr. Poosarla's primary practice is Midwestern Regional Medical Center, at 1430 Paysphere Cir, Chicago, IL 60674 in Cook County. The practice phone is (847) 731-4151.
- Midwestern Regional Medical Center1430 Paysphere Cir, Chicago, IL 60674 · Cook CountyPhone(847) 731-4151
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Teja Poosarla is affiliated with 4 sites of care and 4 medical groups
Dr. Poosarla's primary practice is Midwestern Regional Medical Center in Chicago, Illinois. Dr. Poosarla is also affiliated with City of Hope Cancer Center Chicago. The medical group on file is City of Hope Cancer Center Chicago. Dmand AI also links Dr. Poosarla to 3 more medical groups and 2 group practices and clinics, each named with a free account.
Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. Teja Poosarla's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Poosarla practices, 3 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Midwestern Regional Medical Center | Available with a free account |
| +3 more sites and 3 medical groups | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Teja Poosarla is one of 153 medical oncologists in Illinois
Medical oncology is Dr. Poosarla's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dmand AI has Dr. Poosarla's licenses on file in 3 states: Virginia, Alabama and Mississippi.
Specialties and state licenses
- Medical oncology, VirginiaPrimary
- Hematology and oncology, Alabama
- Mississippi license
Medical oncologists near Dr. Poosarla
Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Teja Poosarla billed Medicare for 399 services in 2024
CMS data shows 399 Medicare services from Dr. Poosarla across 5 procedure codes in 2024, for 203 Medicare patients. Medicare paid $38,109 for them.
Dr. Poosarla's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 2732024: 39946%
Where Dr. Poosarla's Medicare services took place, 2024
- In an office30476%
- In a facility9524%
Dr. Poosarla compared with the Illinois median for medical oncologists, 2024
- Dr. Poosarla
- Illinois median
- Medicare services
- 399vs 67141% below
- Medicare patients
- 203vs 23012% below
- Part D claims
- 530vs 34554% above
Medians across 140 medical oncologists in Illinois with Dmand AI profiles that report each measure.
Dr. Poosarla's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Poosarla?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Poosarla and other medical oncologists in Illinois.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Teja Poosarla treated 203 Medicare patients in 2024, average age 73
CMS counts 203 Medicare patients who saw Dr. Poosarla in 2024. The largest group is 65 to 74, with 96 patients. 75% of them have cancer, and 74% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.70, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Poosarla's median patient age at 66, with 97% women.
Dr. Poosarla's Medicare patients by age, 2024
Dr. Poosarla's Medicare patients by sex, 2024
- Women17988%
- Men2412%
Chronic conditions among Dr. Poosarla's Medicare patients, 2024
- Cancer75%
- High cholesterol74%
- High blood pressure72%
- Arthritis44%
- Diabetes31%
- Osteoporosis31%
- Anxiety27%
- Chronic kidney disease27%
Share of Medicare patients with each condition. A patient can have several.
Dr. Poosarla's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 66
Patient panel by sex, all payers
- Women97%
- Men3%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Teja Poosarla wrote 722 Medicare Part D claims in 2024
In 2024, Dr. Poosarla wrote 722 Medicare Part D claims for 149 patients. 95% of them were for generic drugs. CMS names the drug for 530 of them, across 10 drugs with 11 or more claims each, at $260,416 in total drug cost. In 2023, CMS named 203 claims across 5 drugs.
Dr. Poosarla's Part D claims by kind of drug, 2024
- Generic684 claims95%
- Brand-name38 claims5%
Dr. Poosarla's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 2032024: 530161%
Drugs named by CMS: 10 in 2024, 5 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Teja Poosarla scored 86 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Poosarla for performance year 2024, reported as part of a group. Dr. Poosarla accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Poosarla as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Dr. Poosarla's MIPS scores, performance year 2024
- 86of 100Final score
- 74.2of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
- 67of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Teja Poosarla has 7 publications on record
Dmand AI links 7 papers to Dr. Poosarla, published from 2015 to 2024. 2020 was the busiest year, with 2. The most frequent topics are Black or African American. Dr. Poosarla's most frequent co-authors are Nicolette P. Holliday, MD, Margaret Block, MD and Andrew Jacob Brenner, MD, PhD.
Dr. Poosarla's papers by year, 2015 to 2024
Topics Dr. Poosarla writes about most
- Black or African American
Dr. Poosarla's most frequent co-authors
- Nicolette P. Holliday, MD3 shared papers
- Margaret Block, MD1 shared paper
- Andrew Jacob Brenner, MD, PhD1 shared paper
Recent publications by Dr. Poosarla
Biochim Biophys Acta Rev Cancer
Clin Lymphoma Myeloma Leuk
See who Dr. Poosarla researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Poosarla works with, so you can find a warm path to the right medical oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Teja Poosarla has worked on 5 clinical trials
Dmand AI links Dr. Poosarla to 5 clinical trials. 3 are still active or recruiting. Conditions studied include Breast Neoplasms, Breast Diseases and Brain Neoplasms.
Clinical trials with Dr. Poosarla by phase
- NonePhase 1: no trials
- 1Phase 2: 1 trial
- 1Phase 3: 1 trial
- NonePhase 4: no trials
Conditions in Dr. Poosarla's trials
- Breast Neoplasms
- Breast Diseases
- Brain Neoplasms
- Triple Negative Breast Neoplasms
- Central Nervous System Neoplasms
Investigators on the most trials with Dr. Poosarla
- Ricardo Hugo Alvarez, MD3 shared trials
- Michelina Marie Cairo, MD3 shared trials
- Amy S. Clark, MD3 shared trials
Recent clinical trials with Dr. Poosarla
A Study to Assess Overall Response Rate by Inducing an Inflammatory Phenotype in Metastatic BReast cAnCEr With the Oncolytic Reovirus PeLareorEp in CombinaTion With Anti-PD-L1 Avelumab and Paclitaxel - BRACELET-1 Study (opens in a new tab)
Platinum in Treating Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Teja Poosarla received $6,633 in industry payments from 2016 to 2025
CMS Open Payments shows 190 general payments to Dr. Poosarla from 35 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 44% of the total. AstraZeneca Pharmaceuticals LP paid the most, $2,498.
General payments to Dr. Poosarla by program year, 2016 to 2025
General payments to Dr. Poosarla by kind, 2016 to 2025
- Food and beverage$2,90044%
- Consulting fees$2,72341%
- Education$70311%
- Honoraria$1753%
- Other$1322%
Companies that paid Dr. Poosarla the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Teja Poosarla graduated from University of South Alabama College of Medicine
Dr. Poosarla graduated from University of South Alabama College of Medicine in 2012.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Teja Poosarla's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Teja Poosarla
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Teja Poosarla's NPI number?
Dr. Teja Poosarla's NPI number is 1932467792. It was assigned on May 1, 2012, and it is active in the NPI Registry.
What kind of doctor is Dr. Teja Poosarla?
Dr. Teja Poosarla is a medical oncologist in Chicago, Illinois. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).
Where does Dr. Teja Poosarla practice?
Dr. Poosarla practices at 1430 Paysphere Cir, Chicago, IL 60674. Dr. Poosarla's primary practice is Midwestern Regional Medical Center in Chicago, Illinois. Dmand AI also links Dr. Poosarla to 3 medical groups and 2 group practices and clinics.
What is Dr. Teja Poosarla's office phone number?
The practice phone on file for Dr. Poosarla is (847) 731-4151.
What is Dr. Teja Poosarla's medical license number?
Dr. Poosarla holds Virginia license 0101273767, one of the licenses on file in 3 states.
Which states has Dr. Teja Poosarla been licensed in?
Dmand AI has state licenses on file for Dr. Poosarla in Virginia, Alabama and Mississippi.
Which hospitals is Dr. Teja Poosarla affiliated with?
Dr. Poosarla is affiliated with City of Hope Cancer Center Chicago.
What medical group is Dr. Teja Poosarla part of?
Dr. Poosarla is linked to City of Hope Cancer Center Chicago. Dmand AI links Dr. Poosarla to 3 more medical groups.
Does Dr. Teja Poosarla accept Medicare?
Yes. CMS data shows Dr. Poosarla billed Medicare for 399 services in 2024, and Dr. Poosarla accepts Medicare assignment.
Does Dr. Teja Poosarla offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Poosarla as offering telehealth services.
Show 9 more questionsShow fewer questions
What is Dr. Teja Poosarla's MIPS score?
Dr. Poosarla's MIPS final score for performance year 2024 is 86 out of 100, reported as part of a group.
How many Medicare patients does Dr. Teja Poosarla see?
CMS counts 203 Medicare patients who saw Dr. Poosarla in 2024, with an average age of 73.
What services does Dr. Teja Poosarla bill to Medicare?
In 2024, Dr. Poosarla's most billed Medicare services were office visit, established patient (99214), office visit, established patient (99215) and office visit, new patient (99205).
Where did Dr. Teja Poosarla go to medical school?
Dr. Poosarla graduated from University of South Alabama College of Medicine in 2012.
What drugs does Dr. Teja Poosarla prescribe most?
In 2024 Medicare Part D data, Dr. Poosarla's most prescribed drugs by claims were Letrozole, Anastrozole and Tamoxifen Citrate.
Has Dr. Teja Poosarla received payments from drug or device companies?
CMS Open Payments shows $6,633 in general payments to Dr. Poosarla from 35 companies from 2016 to 2025. The largest total came from AstraZeneca Pharmaceuticals LP.
How long has Dr. Teja Poosarla been practicing?
Dr. Poosarla graduated from medical school in 2012, 14 years ago.
Does Dr. Teja Poosarla do research?
Dmand AI links 7 publications to Dr. Poosarla, published from 2015 to 2024. Dr. Poosarla has worked on 5 clinical trials.
Who does Dr. Teja Poosarla publish with?
Dr. Poosarla's most frequent co-authors are Nicolette P. Holliday, MD (3 shared papers), Margaret Block, MD (1 shared paper) and Andrew Jacob Brenner, MD, PhD (1 shared paper).
Selling to medical oncology practices?
See medical oncologists in Illinois by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card